Identify qualified participants for clinical trials
As much as 90 percent of volunteers for a given clinical trial are not appropriate subjects, leading to excessive recruitment costs and inefficient trial environments. PWN enables pre-screening of a participant’s lab values that identifies inclusionary and exclusionary biomarkers to qualify participants before they get to the trial site.
- Reduce recruitment costs
- Increase trial speed
- Ease the burden on trial staff